| Production of a diagnostic monoclonal antibody in perennial alfalfa plants H Khoudi, S Laberge, JM Ferullo, R Bazin, A Darveau, Y Castonguay, ... Biotechnology and Bioengineering 64 (2), 135-143, 1999 | 268 | 1999 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 240 | 2021 |
| Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike J Prévost, R Gasser, G Beaudoin-Bussières, J Richard, R Duerr, ... Cell Reports Medicine 1 (7), 2020 | 221 | 2020 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 191 | 2021 |
| Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, ... MBio 11 (5), 10.1128/mbio. 02590-20, 2020 | 178 | 2020 |
| Therapeutic intravenous immunoglobulins R Lemieux, R Bazin, S Néron Molecular immunology 42 (7), 839-848, 2005 | 173 | 2005 |
| Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset SP Anand, J Prévost, M Nayrac, G Beaudoin-Bussières, M Benlarbi, ... Cell Reports Medicine 2 (6), 2021 | 172 | 2021 |
| Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood–brain barrier I St-Amour, I Paré, W Alata, K Coulombe, C Ringuette-Goulet, ... Journal of Cerebral Blood Flow & Metabolism 33 (12), 1983-1992, 2013 | 172 | 2013 |
| Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming S Selleri, P Bifsha, S Civini, C Pacelli, MM Dieng, W Lemieux, P Jin, ... Oncotarget 7 (21), 30193, 2016 | 157 | 2016 |
| Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset J Perreault, T Tremblay, MJ Fournier, M Drouin, G Beaudoin-Bussières, ... Blood, The Journal of the American Society of Hematology 136 (22), 2588-2591, 2020 | 130 | 2020 |
| Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 R Gasser, M Cloutier, J Prévost, C Fink, É Ducas, S Ding, N Dussault, ... Cell reports 34 (9), 2021 | 101 | 2021 |
| Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation É Aubin, R Lemieux, R Bazin Blood, The Journal of the American Society of Hematology 115 (9), 1727-1734, 2010 | 98 | 2010 |
| IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology I St-Amour, I Paré, C Tremblay, K Coulombe, R Bazin, F Calon Journal of neuroinflammation 11, 1-16, 2014 | 89 | 2014 |
| Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses A Tauzin, SY Gong, G Beaudoin-Bussières, D Vézina, R Gasser, L Nault, ... Cell host & microbe 30 (1), 97-109. e5, 2022 | 83 | 2022 |
| Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas. R Bazin, R Lemieux Journal of immunology (Baltimore, Md.: 1950) 139 (3), 780-787, 1987 | 70 | 1987 |
| Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6) R Bazin, R Lemieux Journal of immunological methods 116 (2), 245-249, 1989 | 66 | 1989 |
| Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg) DP Proulx, É Aubin, R Lemieux, R Bazin Clinical immunology 135 (3), 422-429, 2010 | 64 | 2010 |
| Reversal of immune thrombocytopenia in mice by cross‐linking human immunoglobulin G with a high‐affinity monoclonal antibody R Bazin, R Lemieux, T Tremblay British journal of haematology 135 (1), 97-100, 2006 | 60 | 2006 |
| SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses D Chatterjee, A Tauzin, L Marchitto, SY Gong, M Boutin, C Bourassa, ... Cell reports 38 (9), 2022 | 57 | 2022 |
| Tetramolecular immune complexes are more efficient than IVIg to prevent antibody‐dependent in vitro and in vivo phagocytosis of blood cells R Bazin, R Lemieux, T Tremblay, I St‐Amour British journal of haematology 127 (1), 90-96, 2004 | 49 | 2004 |
